- Report
- March 2022
- 180 Pages
Global
From €3281EUR$3,456USD£2,767GBP
- Book
- May 2023
- 272 Pages
- Book
- October 2019
- 184 Pages
- Book
- August 2019
- 264 Pages
- Book
- January 2018
- 144 Pages
- Book
- December 2016
- 528 Pages
- Book
- January 2016
- 408 Pages
- Book
- October 2013
- 144 Pages

Atrial Fibrillation (AF) is a common cardiac arrhythmia that affects millions of people worldwide. It is characterized by an irregular and rapid heart rate, which can lead to a variety of symptoms, including palpitations, shortness of breath, and fatigue. AF can also increase the risk of stroke and other cardiovascular complications. Treatment options for AF include lifestyle modifications, medications, and catheter ablation.
The AF market is a rapidly growing segment of the cardiology industry. It is driven by an aging population, increasing prevalence of AF, and the development of new technologies and treatments. The market is expected to continue to grow in the coming years, driven by the increasing demand for better diagnosis and treatment of AF.
Some of the major companies in the AF market include Medtronic, Boston Scientific, Abbott, Biosense Webster, and St. Jude Medical. Show Less Read more